1 | 1.0 MIU IL-2 PER DAY | - | - | - | - | 1件: 2 2 💬
|
2 | 2.0 MIU IL-2 PER DAY | - | - | - | - | 1件: 2 2 💬
|
3 | ANTI-IL-20 | 1件: Fletikumab Fletikumab (Anti-IL-20) | 1件: Fletikumab
Fletikumab
💬
| 1件: IL20 IL20 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 💬
|
4 | ANTI-IL-23 monoclonal antibody | - | - | - | - | 1件: 96 96 💬
|
5 | Anticorpo monoclonale anti IL-23 | - | - | - | - | 1件: 96 96 💬
|
6 | Anticorpo monoclonale ANTI-IL-23 | - | - | - | - | 1件: 96 96 💬
|
7 | IL-2 | 1件: Human interleukin-2 Human interleukin-2 (IL-2) | - | - | - | 5件: 2 2, 46, 49, 51, 53 💬
|
8 | IL-23 therapy | - | - | - | - | 1件: 96 96 💬
|
9 | LOW-dose IL-2 | - | - | - | - | 1件: 56 56 💬
|
10 | LOW-dose IL-2 administration | - | - | - | - | 1件: 96 96 💬
|
11 | Recombinant human anti IL-22 monoclonal antibody IGG1 | - | - | - | - | 1件: 46 46 💬
|
12 | UTTR1147A, IL22-FC, IL-22FC | 1件: Efmarodocokin alfa Efmarodocokin alfa (IL-22Fc) | 1件: Efmarodocokin alfa
Efmarodocokin alfa
💬
| 1件: IL22 IL22 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬 | 2件: 96 96, 97 💬
|